|
James J. Bochnowski is General Partners of Delphi Ventures, which he founded in 1988. His focus is on biotechnology, medical devices and diagnostics. Mr. Bochnowski began investing in medical companies in 1981 after co-founding Technology Venture Investors (TVI), a private venture capital partnership.
Since 1984, he has focused exclusively on healthcare investments. From 1976 to 1980, Jim was with Shugart Associates, a venture-backed disk drive company. As President and CEO, he led Shugart to increasing profitability, with annual revenues growing from $13 million to $200 million. Shugart was acquired by Xerox in 1979. From 1972 to 1976,
Mr. Bochnowski was a general partner with Donaldson Lufkin & Jenrette's (DLJ) venture capital arm, the Sprout Capital Group. Prior to that, he served as a securities analyst with DLJ.
Mr. Bochnowski earned his M.B.A., with Distinction, from Harvard University in 1969 and B.S. in aerospace engineering from the Massachusetts Institute of Technology. Trained as an aerospace engineer, Mr. Bochnowski worked as a missile systems engineer with the U.S. Army Missile Intelligence Directorate before entering Harvard University. Mr. Bochnowski has served as a director of the Western Association of Venture Capital.
| 